Editorial Statement

Forum of Infection is a peer-reviewed, interdisciplinary scientific journal devoted to the publication of articles ordered by Editorial Board. The scope of journal covers original papers, pilot studies, case reports, reviews, letters to the Editor, recommendations, articles, commentaries, Editorial notes, historical elaborations, memories, book reviews, reports from symposia and conferences, commentaries to published papers, announcements, abstracts from scientific literature and other works recognized by Editor as valuable ones.

The paper version of the Journal is its primary (reference) version.

General Rules

The articles should be prepared according to the rules established by International Committee of Medical Journal Editors (see N Eng J Med 1997;336:309–315). All articles are published in Polish or English language, however in specific cases, Editor allows a possibility of publication in other language. The article should be written in the succinct, grammatically- correct manner with the use of the correct nomenclature. Editorial corrections are established with Author only when issue concerns objective matter on the basis of merit; in any other case, corrections might be performed without Author’s agreement.

In the cover letter, authors should confirm that article has not been published before or it is not submitted elsewhere. The Editorial Office accepts only articles that are classified by Reviewers as comprehensive with the scope of the Journal and contributing a new values to the scientific progress with special acknowledgement to the clinical knowledge. The signatures of authors on the title page of the article are equivalent with the announcement that:

• Article is common work of all Authors;

• Results of research were not published before and are not submitted elsewhere.

The attached approval of chiefs of departments for the publication is unnecessary. The Editorial Office concedes that such agreement was established between Authors and chiefs of the departments. The authors obtain confirmation of article’s submission for review. Articles are reviewed by reviewers and, if it is necessary, by statistical consultant.

The Ethical Conventions

The Editorial Office observes the rules of Helsinki Declaration and requires from Authors that all researches involving human subjects must be in compliance with the rules of Helsinki In case of animal research, it is necessary to observe international principles and guidelines for the use of animals in research, testing and education, developed and published by New York Academy of Science, Commission on Animal Research. The approval of bioethical commission to conduct research on the human subjects or animals is also required and should.

Data Confidentiality Patient

Editorial Office does not allow a manipulation or changing patients’ data that might allow to identify the patient. Authors should protect patient’s privacy and publish only data that are essential for scientific purposes. Use of any information that may reveal personal data of patient (e.g. number of disease history, initials, photography of face, pictures of results containing personal data of patient, etc) is not allowed. If article contains any data revealing identity of patient, authors are obliged to have written approval for publication of these results signed by patient or his counsellor. Use of any data concerning race; ethnic, cultural identity or religious believes are acceptable only if such information is essential for scientific purpose or it has an impact on the course or treatment of

Authors Statement

Editorial Office observes all procedures securing originality of scientific papers. Submission of Authors Statement, together with manuscript, is a preliminary condition for further editorial processing of the article. Authors Statement should be signed by all Authors and send to the office in original version. If above mentioned conditions are not fulfilled, article is rejected from further editorial processing. Statement should be written in the following manner:

Hereby we announce, that we are the Authors of article and together we declare that article fulfils all formal and ethical requirements of scientific works. The Article:

1. Has not been submitted elsewhere and has not been published before in another journal, book, elaboration (in printed or electronic form, as an e-book or part of internet publication).

2. Is not under consideration for submission in another Editorial Office.

3. Was performed according to the principles of Good Clinical Practice and according to the binding international conventions, especially in compliance to Helsinki Declaration of Human Rights.

4. Was performed with necessary care concerning patients’ rights and experimental animals rights (with respect for patient’s privacy and with approval of ethical commission on conducting the animal research).

5. Was performed with factual and intellectual contribution of all mentioned authors. The specific impact and contribution is following:

Author: [ ] project of research, [ ] collection of data/material, [ ] choice of methodics, [ ] choice of statistical analysis and statistical analysis, [ ] collection and compilation of results, [ ] preparation of manuscript, [ ] choice and selection of bibliography, [ ] fund-raising;

6. Was performed according to the best knowledge of authors and with observation of appropriate carefulness during collection, development and statistical analysis of collected data.

7. Is not a merit of conflict of interest between Authors and other institutions, companies or organizations, and if such took place (e.g. cooperation with commercial institutions in the scope of financing), such declaration is required to be placed in the article in the clear and visible manner.

We issue the following declaration with the awareness of legal and ethical consequences that are result of declaring untruth. We understand that Editorial Office stipulates the right to verify the originality of article and to reject the article in case of transgression of above mentioned rules. We agree that Editorial Office has the right to inform Authors’ supervisor and scientific societies, editors associations and other adequate institutions about such transgression.

The Editorial Office has a right to point the object and scope of transgression. We announce that all Authors are conscious of this article and agree with its content. The following statement should be attached to the submitted article.

 

Ghostwriting and Guest Autorship – Honorary Autorship

It is essential for Editorial Office to publish only articles that contain clear declaration of transparency, information concerning potential conflict of interest and Statement of Authors containing clear and visible indication of specific Authors’ contribution to the process of article’s preparation. The purpose of these requirements is elimination of all types of scientific misconduct. These are ghost writing (a situation where a person contributes significantly to a publication and is not disclosed as one of the authors or named in the acknowledgments) or guest authorship – honorary authorship (a situation where an author’s contribution is insignificant or non-existent and he is still listed as co-author of a publication).

The Editorial Office reserves a right to verify an originality of submitted article and to reject an article if binding rules are transgressed. The Editorial Office reserves a right to unmask such practices and to inform the Authors’ employers, all societies and other objects related to scientific activity of authors, that transgression had place, and to point the object and the scope of transgression.

 

Declaration of Transparency, Acknowledgements

Acknowledgements for persons or institutions that had impact on article creation, should be indicated in footage at the end of the article. Besides acknowledgements, sources of material support – grants, donations and subventions – should be mentioned, as well as bioethical commission approval for conduct of research, or trials on devices, drugs, etc, if necessary, should be presented there.

Conflict of interests

Authors are required to disclose financial commitments, if any exist, between authors and company, that product is presented in the subjected article or the company competing with above mentioned company. The Editorial Office recognizes these data as confidential and underlines that they have no impact on the relevant evaluation of the article. The form of these data presentation is going to be established between Editorial Office and Authors before publication. If Editorial Office does not secede from publication, data concerning sources of donations, will be placed at the end of the article, before The Journal’s regulation requires that Reviewers and employees of Editorial Office have written the official letter to the Leading Editor – that there are any relationship between them and external institutions. Such letter should reveal the potential agreements between commercial company related to the medical product that is described in the submitted article.

Reviewing Process

The Editorial Office stays in compliance to the guidelines of Uniform Requirements for Manuscripts submitted to Biomedical Journals ICMJE and guidelines of Ministry of Science and Higher Education concerning methods of articles.

Given articles are submitted for initial evaluation (first look) to evaluate, whether articles are in scope of the Journal. If they are not, main Author of the article will be informed about this fact immediately, and review process is going to be stopped. When initial evaluation is done, detailed review is performed by two independent reviewers.

They are required to be not from the same unit as Authors of article or the Editors Office. If article is submitted in the English language, at least one of the reviewers is required to be affiliated in the foreign institution in relation to the nationality of Authors of article.

In case of two positive notes, article is accepted for publication. If reviews are discrepant, Main Editor calls 3rd reviewer. His opinion concerning value of the article is decisive. The Editorial Office strictly observes the rule of “double-blind review process”. Identity of authors are blinded to the reviewers and vice-versa.

Review is required to be presented in the written form and contain unambiguous conclusion concerning refusal or acceptance of the article. The conclusive decision concerning qualification of article for publication is possible, only if Author corrects his work according to the guidelines proposed by Reviewers. In specific cases, The Editorial Office keeps the right to refuse publication, with giving no clarification of the decision.

Reviewers

Editorial Board

MD, PhD Anna Chrapusta, Burns and Plastic Surgery Centre of Malopolska, Ludwik Rydygier Memorial Hospital in Krakow, Poland
MD, PhD Grzegorz Ciesielski, University of Tampere, Institute of Biomedical Technology, Finland
PhD Adam Domanasiewicz, St. Jadwiga Slaska Hospital in Trzebnica, Department of General Surgery, Poland
MD, PhD, Prof. Stefania Giedrys-Kalemba, Medical University of Szczecin, Department of Microbiology and Immunology, Poland
MD, PhD Mirosława Malara, Individual Public Clinical Hospital of Medical University of Katowice, Poland
MD, PhD, Prof. Andrzej Gładysz, Medical University of Wroclaw, Department of Infectious Diseases, Liver Diseases and Acquired Immunodeficiency, Poland
MD, PhD, Prof. Grażyna Gościniak, Medical University of Wroclaw, Department of Microbiology, Poland
MD, PhD, Prof. Andrzej Horban, National Consultant of Infectious Diseases, Warsaw Medical University, Department of Infectious Diseases, Poland
MD, PhD, Prof. Jacek Imiela, Specialistic Hospital in Warsaw, Department of Internal Diseases and Nephrology, Poland
MD, PhD, Prof.  Andrzej Jankowski, Medical University of Poznan, Department and Clinic of Surgery, Traumatology and Children’s Urology, Poland
MD, PhD, Prof. Arkadiusz Jawień, University Hospital No. 1 Antoni Jurasz Memorial Hospital in Bydgoszcz, Department and Clinic of Vascular Surgery and Angiology, Poland
MD, PhD Mariusz Kózka, Military Clinical Hospital No. 5 in Krakow, Department of Surgery, Poland
MD, PhD, Prof. Tomasz Kręcicki, Jan Mikulicz-Radecki Memorial University Clinical Hospital in Wroclaw, Clinic of Otolaryngology, Head and Neck Surgery, Poland
MD, PhD, Prof. Wojciech Kustrzycki, Jan Mikulicz-Radecki Memorial University Clinical Hospital in Wroclaw, Clinic of Heart Surgery, Poland
MD, PhD, Krzysztof Kuszewski, National Institute of Public Health,  Department of  Organisation and Economics of Health Care and Hospitality, Poland
MD, PhD, Prof. Sławomir Majewski, Medical University of Warsaw, Institut of Venereology, Poland
MD, PhD, Prof. Joanna Narbutt, Medical University of Lodz,  Clinic of Dermatology and Venereology, Poland
MD, PhD, Prof. Georg Peters, University of Münster, Institut of Medical Microbiology, Germany
MD, PhD, Prof. Tadeusz Płusa, Military Medical Institute in Warsaw, Clinic of Internal Diseases, Pneumology and Allergology, Poland
MD, PhD, Prof. Anna Przondo-Mordarska, Medical University of Wroclaw, Department of Microbiology, Poland
MD, PhD, Prof. Stefan Sajdak, Memorial Karol Jonscher Hospital of Medical University of Poznan, Clinic of Operating Gynecology, Poland
MD, PhD, Prof. Krzysztof Simon, Memorial J. Gromkowski Specialistic Hospital in Wroclaw, I Department of Infectious Diseases, Poland
MD, PhD, Prof. Jadwiga Snarska, University of Warmia and Mazury, Department of Surgery, Poland
MD, PhD, Prof. Maria T. Szewczyk, Ludwik Rydygier Memorial Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Department of Surgery Nursing, Poland
MD, PhD, Prof. Maciej Wilczak, Medical Uniwersity of Poznan, Department of Medical Education, Poland
MD, PhD, Prof. Wojciech Witkiewicz, Specialistic Hospital in Wroclaw, Department of Vascular Surgery, Poland
MD, PhD Kamil Wolyniec, University of Mellbourne, Sir Peter MacCallum Department of Oncology, Austrialia
MD, PhD  Marzena Zielińska, Medical University of Wroclaw, Department of Anesthesiology and Intensive Care, Poland

Outside Reviewers

PROBIOTICS AND GASTROENTEROLOGY

  1. MD, PhD Piotr Albrecht –  Clinic of Gastroenterology and Children’s Nutrition, Medical University of Warsaw
  2. MD, PhD, Prof. Mieczysława Czerwionka-Szaflarska –  Department and Clinic of Pedriatics, Allergology and Gastroenterology, Nicolaus Copernicus University
  3. MD, PhD Agnieszka Krzywicka – Clinic of Gastroenterology of Pediatrics Clinic in Zabrze
  4. MD, PhD Monika Męglicka – Clinic of Gastroenterology, Hepathology, Nutrition Diseases and Pediatrics, Center of Children’s Health, Warsaw
  5. MD, PhD Prof. Hanna Szajewska – Clinic of Gastroenterology and Children’s Nutrition, Medical University of Warsaw
  6. MD, PhD Małgorzata Jelińska – Department of Bromathology, Medical University of Warsaw
  7. MD, PhD, Prof. Barbara Iwańczak –  II Department and Clinic of Pediatrics, Gastroenterology nad Nutrition, Medical University of Wroclaw

 DISINFECTION AND HYGIENE

  1. MSc Małgorzata Cichońska – Center of Health Care in Ostrowiec Swietokrzyski
  2. MSc Maria Ciuruś – Department of Nursing with Practical Labs, Medical University of Lodz
  3. MSc Dorota Kudzia-Karwowska – Sterilization Center of Medical University of Katowice
  4. MSc Elżbieta Kutrowska – Department of Sterilization, St. Adalbert Specialistic Hospital in Gdansk
  5. MSc Joanna Włodarczyk-Rajska –  Department of Sterilization of Oncology Center in Warsaw
  6. MSc Małgorzata Cichońska – Center of Health Care in Ostrowiec Swietokrzyski
  7. MD, PhD, Prof. Jacek J. Klawe – Deoartnebt of Hygiene and Epidemiology, Collegium Medicum, Bydgoszcz

EPIDEMIOLOGY

  1. MD, PhD, Prof. Małgorzata Bulanda – Department of Epidemiology of Infections, Jagiellonian University
  2. MD, PhD Grażyna Dulny – Department of Prevention of Environmental Hazards and Allergology of Medical Uniwersity of Warsaw, Central Clinical Hospital in Warsaw
  3. MD, PhD Paweł Grzesiowski – Association of Medical Hygiene, Institut of Infection Prevention in Warsaw
  4. MD, PhD Beata Ochocka – National Consultant of Epidemiological Nursing, Clinical Hospital of Medical University of Katowice
  5. MSc Małgorzata Sobania –Vice President of Polish Epidemiological Nurses Association, Pomeranian Center of Infectious Diseases and Tuberculosis in Gdansk
  6. MD, PhD Grzegorz Ziółkowski – Department of Microbiology and Epidemiology, Specialistic Hospital in Sosnowiec
  7. MD, PhD Bogusława Serzysko – Hearth Diseases Center, Epidemiology Unit, Zabrze

MEDICAL MICROBIOLOGY

  1. MD, PhD Małgorzata Dawgul – Department of Inorganic Chemistry, Laboratory of Medicine, Medical University of Gdansk
  2. MD, PhD Artur Drzewiecki – Department of Medical Microbiology, Jagiellonian University in Krakow
  3. MD, PhD, Prof. Eugenia Gospodarek –  Department of Microbiology, Collegium Medicum, Bydgoszcz
  4. MD, PhD Katarzyna Jermakow – Department of Microbiology, Medical University of Wroclaw
  5. MD, PhD Monika Łysakowska – Department of Medical and Sanitary Microbiology, Medical Univeristy in Lodz
  6. MD, PhD Anna Majewska – Department of Medical Microbiology, Medical University of Warsaw
  7. MD, PhD, Prof. Gayane Martirosian – Department of Medical Microbiology, Medical University of Katowice
  8. MD, PhD Elżbieta Mazur – Department of Medical Microbiology, Medical University of Lublin
  9. MD, PhD, Prof. Grażyna Młynarczyk – Department of Medical Microbiology, Medical University of Warsaw
  10. MD, PhD Agnieszka Sikora – Department of Medical Microbiology, Medical University of Lublin
  11. MD, PhD, Prof.  Andrzej Szkaradkiewicz – Department of Medical Microbiology, Medical University of Poznan

VIROLOGY

  1. MD, PhD, Prof. Małgorzata Polz-Dacewicz – Department of Virology, Medical University of Lublin
  2. MD, PhD Prof. Tomasz J.Wąsik – Department of Microbiology and Virology, Medical University of Katowice

MYCOLOGY

  1. MD, PhD Urszula Nawrot – Department of Microbiology, Medical University of Wroclaw

INFECTION PREVENTION AND VACCINOLOGY

  1. MD, PhD Ewa Duszczyk – Department of Infectious Diseases of Children, Medical University of Warsaw, Hospital for Infectious Diseases in Warsaw
  2. MD, PhD Ernest Kuchar – Department and Clinic of Pediatrics and Infectious Diseases, Medical University of Wroclaw
  3. MD, PhD, Prof. Leszek Szenborn – Department and Clinic of Pediatrics and Infectious Diseases, Medical University of Wroclaw
  4. MD, PhD, Prof. Joanna Zajkowska – Clinic of Infectious Diseases and Neuroinfection, Medical University of Bialystok

HBV , HCV I HIV INFECTIONS

  1. MD, PhD, Prof. Anna Boroń-Kaczmarska – Department and Clinic of Infectious Diseases and Hepatology, Medical University of Szczecin
  2. MD, PhD Aneta Cybula-Walczak –  Clinic of Hepatology and Acquired Immunodeficiency, Medical University of Warsaw
  3. MD, PhD, Prof. Robert Flisiak – Clinic of Infectious Diseases and Hepatology, Medical University of Białystok
  4. MD, PhD Aleksander Garlicki – Department of Gastroenterology and Infectious Diseases, Jagiellonian University in Krakow
  5. MD, Phd, Prof. Brygida Knysz – Deaprtment of Infectious Diseases, Liver’s Diseases, and Acquired Immunodeficiency, Medical University of Wroclaw
  6. MD, PhD Joanna Kozłowska – Clinic of Hepatology and Acquired Immunodeficiency, Medical University of Warsaw
  7. MD, PhD, Prof. Małgorzata Pawłowska –  Department of Infectious Diseases and Hepatology, Ludwik Rydygier Memorial Collegium Medicum in Bydgoszcz
  8. MD, PhD, Henryka Mięgoć –  Clinic of of Infectious Diseases and Hepatology, Medical University of Bialystok
  9. MD, PhD, Ass. Prof. Anna Piekarska – Department and Clinic of Infectious Diseases and Hepatology, Medical University of Lodz

INTENSIVE CARE

  1. MD, PhD Alicja Bartkowska-Śniatkowska – Medical University of Poznan, [Department of Anesthesiology and and Intensive Pediatric Care
  2. MD, PhD Mirosław Czuczwar – Clinic of Anesthesiology and Intensice Care, Medical University of Lublin
  3. MD, PhD Bartosz Horosz – Department of Anesthesiology and Intensice Care,  Public Hospital Named Prof. Witold Orłowski, Warsaw
  4. MD, PhD Sylweriusz Kosiński – Department of Anesthesiology and Intensive Care of Lungs Disesases Hospital in Zakopane
  5. MD, PhD Urszula Zielińska-Borkowska – Department of Anesthesiology and Intensive Care, Clinical Hospital named Witold Orłowski in Warsaw

LEGAL ASPECTS OF HOSPITAL INFECTION

  1. MA Urszula Drozdowska – Zakład Prawa Cywilnego Uniwersytet w Białymstoku [Department of Civil Law, University of Bialystok

HEMATOLOGY

  1. MSc Małgorzata Giemza – Hospital Infection Control Unit, Institute of Hematology and Transfusion
  2. MD, PhD, Prof.  Piotr Rzepecki – Centre of Bone Marrow Transplant, Clinic of Oncology, Military Medical Institute in Warsaw
  3. MD, PhD Jolanta Stefaniak – Department of Children Hematology and Oncology, Medical University of Lublin
  4. MD, PhD, Prof. Jan Styczyński – Department of Pediatrics, Hematology and Oncology, Ludwik Rydygier Memorial Collegium Medicum in Bydgoszcz

ALLERGOLOGY

  1. MD, PhD, Prof. Tadeusz Płusa – Department of Internal Diseases, Pneumonology and Allergology, Medical Military Institute

Reviewers of the Journal are members of Scientific Board of the Journal. List of the members is published in every number of Journal and is constantly accessible at the Journal website. Members of Scientific Board of Journal are recognized professionals from the different branches of the medicine. It guarantees versatility of the evaluation. If Editorial Office considers article valuable, although the topic is not strictly contained in the Journal’s scope, Main Editor has got the right to acclaim the reviewer from outside of the Scientific Board.

The Reviewers might accept article without corrections, accept it after minor changes, accept it after major changes, send it for another review or to reject the article. If two reviews are positive, the Main Editor prepares one collective review and sends it to the Author, so he might take a stance towards Reviewers’ opinions.

Rules of acceptance or rejection of article, as well as formulary of review are available at http://forumzakazen.pl, on the website of the Journal.

Permissions

The Materials (printed or electronic), taken from sources protected by author laws and other related laws, should be sent to the Editorial Office together with the written approval of the owner (Author or Editor) of rights to reproduce given material. Source materials will be not published, if such approval is not delivered. The written approval of the main Author is also necessary to refer the articles in the process of printing. The Editorial Office requires also the written approval, if Author uses oral data or unpublished data obtained from the other person.

Transfer of Author Rights

If article is accepted for publication, Author is required to perform final correction of article, according to the reviewers comments, during next 48 hours. Corrections sent to the Editorial Office later are not going to be taken into account. Authors are also obliged to sign the agreement concerning transfer of author rights as a condition of publication.

Thereby, Author confirms that he transfers automatically all author rights for editing and propagating of sent materials on the all known fields of application on the Editor for free. Moreover, Author agrees that article is not going to be published (or translated) elsewhere, without earlier approval of recipient of the author rights – The Editor. For the period of time, which starts with the acceptance of article in the Editorial Office and ends with the print of article, data contained in the article might not be published in press, till the time of release of the number of “Infections Forum” that contains mentioned article.

Civil liability

Editorial Office, Scientific Board and Editor make all efforts to present only true and authentic data and opinions. But yet, it has to be underlined that not above mentioned subjects, but Author and marketing company are responsible for authenticity of the content of article or advertisement, respectively. Presented data, diagnostic decisions and treatment cannot be treated as a sole basis for clinical decision, but rather as an exemplary development of the specific clinical cases. The person responsible for clinical decisions should rely on own medical experience. Author and Editor are not responsible for these decisions. It is recommended that doses of the drugs, ways of use of medicinal products or devices, were performed accordingly with the producers’ indications contained on the leaflet and/or as it is recommended by the legal authorities of Reader’s state.